Jpx RNA activates Xist by evicting CTCF

Area of Science:

• Genetics
• Epigenetics
• Molecular Biology

Background:

• Mammalian dosage compensation relies on X chromosome inactivation (XCI) for XX individuals.
• The noncoding Xist RNA initiates XCI, but its precise regulation remains unclear.
• Existing models suggest an X-to-autosome ratio (X:A) dependency, lacking detailed molecular insights.

Purpose of the Study:

• To elucidate the molecular factors governing Xist RNA induction and XCI initiation.
• To investigate the interplay between RNA and protein in regulating Xist transcription.
• To understand the mechanism of CTCF's role in XCI regulation.

Main Methods:

• Investigated molecular titration between an X-encoded RNA and an autosomally encoded protein.
• Analyzed CTCF protein's role in repressing Xist transcription in pre-XCI cells.
• Examined the effect of Jpx RNA upregulation on CTCF binding to the Xist allele.

Main Results:

• Demonstrated that Jpx RNA, an X-encoded molecule, upregulates at the onset of XCI.
• Showed that Jpx RNA binds CTCF protein, an autosomal factor, and releases it from the Xist promoter.
• Confirmed CTCF is an RNA-binding protein titrated by Jpx RNA, thereby activating Xist transcription.

Conclusions:

• Xist induction is dictated by molecular titration between Jpx RNA and CTCF protein.
• Jpx RNA activates Xist by antagonizing CTCF-mediated repression.
• This mechanism highlights the role of long noncoding RNAs in epigenetic regulation via RNA-protein interactions.